Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 2009-07-16
Chief Executive Officer - 2026-03-31
Director of Finance/CFO 60 2022-06-30
Director TitleAgeSince
Director/Board Member 78 2004-08-31
Chairman 68 2021-12-08
Director/Board Member 58 2020-07-08
Date Insider Type Main position Quantity % Market Cap.
20-07-08Tender

Chief Executive Officer

182,953 0.7495%
20-07-08Tender

Director

10,499 0.0430%
20-07-08Tender

Director

27,444 0.1124%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
-1.48%-6.48%-30.24%-0.87% 88.04B
+0.65%+7.40%-20.85%-22.88% 33.26B
+2.63%+7.18%+1.58%-24.20% 13.42B
-1.44%+0.76% - - 9.51B
-2.18%-11.58%-9.49%+505.64% 2.08B
-0.09%-1.54%-29.27%-63.34% 1.43B
-1.18%-6.49%-47.85%-34.04% 826M
-0.31%-0.76%+7.97%-6.61% 789M
-0.06%+4.31%+54.89%-32.46% 754M
Average -0.37%-1.45%-9.16%+40.15% 16.68B
Weighted average by Cap. -0.62%-2.03%-24.10%-1.84%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-